Product Categories
Featured products
Products/Services（20items）
-
![[New Catalog] Sodium Hydroxide Solution](https://image.mono.ipros.com/public/product/image/2087504/IPROS1923051183780901806.png?w=280&h=280)
[New Catalog] Sodium Hydroxide Solution
-
Aseptic liquid medium for antibody pharmaceuticals for regenerative medicine
-
Aseptic liquid medium for antibody pharmaceuticals for vaccine manufacturing
-
Contract manufacturing service for liquid media compliant with GMP for pharmaceuticals.
-
Case Study of Custom Buffer for Drug Discovery
news list
-
Notice of Extension of Expiration Date for Culture Medium Preparation and WFI Grade Water for Buffer
Thank you very much for your continued support of our products. We are pleased to announce that the expiration date for the catalog product "WFI grade water for media preparation and buffers" has been extended from the previous 18 months to 24 months. This will allow for more flexible operations in your inventory management and procurement planning. For details about the applicable products, please contact your sales representative or refer to the product page.
-
Notice of Registration for Poisonous and Deleterious Substances Manufacturing Industry
As of June 18, we have been registered as a manufacturer of toxic and hazardous substances, and we are now able to produce toxic and hazardous materials. For more details, please contact us.
About味の素コージンバイオ
★GMP Grade [A company that provides contract manufacturing of liquid media and buffers for cell therapy and biopharmaceutical companies]
In June 2018, we established Ajinomoto Koji Bio Co., Inc. as a joint venture between Ajinomoto Co., Inc. and Koji Bio Co., Inc. We combined Ajinomoto Co., Inc.'s high-quality amino acids as the foundation for culture media raw materials and their formulation development technology with Koji Bio Co., Inc.'s advanced liquid culture media production technology to launch a contract manufacturing company for clinical culture media necessary for regenerative medicine. Currently, we are engaged in contract manufacturing of liquid media and buffers for customers in cell therapy and biopharmaceuticals, enhancing our significance in the industry.